Nitromethaqualone

Nitromethaqualone
Nitromethaqualone
Systematic (IUPAC) name
2-methyl-3-(2-methoxy-4-nitrophenyl)-4(3H)-quinazolinone
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 340-52-3
ATC code None
PubChem CID 63339
ChemSpider 57006
Chemical data
Formula C16H13N3O4 
Mol. mass 311.29
SMILES eMolecules & PubChem

Nitromethaqualone (Parnox)[1] is an analogue of methaqualone which has similar sedative and hypnotic properties.[2] It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg.[3] However the aromatic nitro group is metabolised to the corresponding aniline which proved to be a mutagen,[4][5] and consequently nitromethaqualone was not developed further due to toxicity concerns.

References

  1. ^ Patent US 3162634 
  2. ^ Szirmai, A. (1963). "Pharmacological and Therapeutic Studies with a New Quinazolone Derivative, Nitromethaqualone". Therapeutische Umschau. Revue therapeutique 20: 542–546. PMID 14101319.  edit
  3. ^ Van Boven, M.; Daenens, P. (1982). "Biotransformation and excretion of nitromethaqualone in rats and humans". Journal of pharmaceutical sciences 71 (10): 1152–1157. doi:10.1002/jps.2600711019. PMID 7143214.  edit
  4. ^ J Pharm Sci 1982, 71(10), p.1152
  5. ^ Annales des Falsifications de l'Expertise Chimique et Toxicologique 1987, 80(854), p.25